Pretreatment predictive factors for primary resistance to nivolumab plus ipilimumab in advanced renal cell carcinoma: a multicenter collaborative study.
Kimihiko Masui; Naoki Hayata; Toshinari Yamasaki; Takahiro Yamaguchi; Toru Kanno; Noriyuki Ito; Koji Yoshimura; Satoru Masui; Takehiko Segawa; Sojun Kanamaru; Kazuhiro Okumura; Hiroyuki Onishi; Yasumasa Shichiri; Satoshi Ishitoya; Takayuki Sumiyoshi; Yuki Kita; Takayuki Goto; Takashi Kobayashi; Atsuro Sawada
Japanese journal of clinical oncology, 09 Jan. 2026, Peer-reviewed, Lead author